Mobile app for tracking psoriasis and psoriatic arthritis symptoms
Psorcast Study: A Smartphone-based Study of Psoriasis and Psoriatic Arthritis
Sage Bionetworks · NCT05621369
This study is testing a smartphone app that helps people with psoriasis and psoriatic arthritis track their symptoms to see if it can improve early detection and treatment of their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sage Bionetworks (other) |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT05621369 on ClinicalTrials.gov |
What this trial studies
This observational study aims to understand the variation in symptoms of psoriasis and psoriatic arthritis using a smartphone app called Psorcast. Participants will record their symptoms through questionnaires and sensors on their iPhones, allowing for frequent monitoring of disease activity. The study focuses on the early detection of the transition from psoriasis to psoriatic arthritis, which is crucial for timely treatment to prevent irreversible joint damage. By collecting weekly data, the study seeks to map treatment responses and disease progression more effectively than traditional methods.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who own a compatible iPhone and can read and understand the official language of their country.
Not a fit: Patients under 18 years old or those without access to a compatible iPhone may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and early intervention for patients with psoriatic diseases.
How similar studies have performed: Other studies utilizing mobile health technologies for chronic disease monitoring have shown promising results, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult age 18 and older who consent to participate in the study * Own a compatible iPhone or iPod Touch device running iOS 12.2 or above * Be able to read and understand an official language of the country of participation Exclusion Criteria: * Age 17 years or younger * Not a resident of the a country where the app is approved for use * Not have a personal (i.e., not shared) iPhone (4s or newer running iOS 8.0 or later) * Not be able to read and understand an official language of the country of participation
Where this trial is running
Seattle, Washington
- Sage Bionetworks — Seattle, Washington, United States (RECRUITING)
Study contacts
- Principal investigator: Solveig Sieberts, Ph.D — Sage Bionetworks
- Study coordinator: Solveig K Sieberts, Ph.D
- Email: psorcast@sagebase.org
- Phone: 206-928-8266
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Psoriatic Arthritis, Psoriasis, Psoriatic Conditions, Dermatologic Disease, Rheumatologic Disease, Psoriatic Nail, Plaque Psoriasis, Joint Pain